Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for ...

The company claims to have decoded human cell rejuvenation and identified potential gene targets for therapies that treat ...

MX2 wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure and then trap them or even take them apart.

The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next ...

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...

LCA16 is a retinal dystrophy resulting from a genetic mutation which expresses a critical ion channel in retinal pigment epithelium cells.

In this GEN webinar, Ravi Goel Lal from the Arnold lab at Caltech will present the basics and applications of Active Learning ...

Researchers suggest findings could help to pinpoint cell types most vulnerable to conditions such as schizophrenia, and ...

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...

By creating a more sustainable and competitive bioeconomy, customers will get dependable, competitively priced products.

The company is developing molecules that boost the ubiquitin-independent protein degradation activity of 20S proteasomes in complex disorders.

Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially ...